Skip to main content

Prof. Dr. Dagmar Dilloo

Member

Department of Pediatric Haematology & Oncology

Medical Faculty, University of Bonn University Hospital of Bonn Adenauerallee 119 53113 Bonn

Website

Dagmar Dilloo

Recent publications

  • Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.

    The Lancet. Oncology

    Authors: Selim Corbacioglu, Holger Lode, Susanne Ellinger, Florian Zeman, Meinolf Suttorp, Gabriele Escherich, Konrad Bochennek, Bernd Gruhn, Peter Lang, Marius Rohde, Klaus Michael Debatin, Daniel Steinbach, Andreas Beilken, Ruth Ladenstein, Rainer Spachtholz, Peter Heiss, Dirk Hellwig, Anja Tröger, Michael Koller, Karin Menhart, Markus J Riemenschneider, Saida Zoubaa, Silke Kietz, Marcus Jakob, Gunhild Sommer, Tilman Heise, Patrick Hundsdörfer, Ingrid Kühnle, Dagmar Dilloo, Stefan Schönberger, Georg Schwabe, Irene von Luettichau, Norbert Graf, Paul-Gerhardt Schlegel, Michael Frühwald, Norbert Jorch, Michael Paulussen, Dominik T Schneider, Markus Metzler, Alfred Leipold, Michaela Nathrath, Thomas Imschweiler, Holger Christiansen, Irene Schmid, Roman Crazzolara, Naghmeh Niktoreh, Gunnar Cario, Joerg Faber, Martin Demmert, Florian Babor, Birgit Fröhlich, Stefan Bielack, Toralf Bernig, Johann Greil, Angelika Eggert, Thorsten Simon, Juergen Foell

    View this publication
  • The PI3K inhibitor pictilisib and the multikinase inhibitors pazopanib and sorafenib have an impact on Rac1 level and migration of medulloblastoma in vitro.

    Journal of cellular and molecular medicine

    Authors: Leonie F Schoen, Rogerio B Craveiro, Torsten Pietsch, Thomas Moritz, Anja Troeger, Silvia Jordans, Dagmar Dilloo

    View this publication
  • Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trial.

    Pediatric blood & cancer

    Authors: Kerstin Mezger, Sabine Ebert, Hannah Elisa Muhle, Udo Zur Stadt, Arndt Borkhardt, Dagmar Dilloo, Jörg Faber, Tobias Feuchtinger, Thomas Imschweiler, Norbert Jorch, Arnulf Pekrun, Irene Schmid, Franziska Schramm, Martin Zimmermann, Martin A Horstmann, Gabriele Escherich

    View this publication